Quincy Bioscience
TINA.org investigated Quincy Bioscience’s marketing of its brain supplement Prevagen, and was involved as amicus curiae in two separate lawsuits filed against the company. To read more about those efforts, click here.
Brands
Featured
Prevagen Memory Study Falls Short
TINA.org, AARP and others file legal brief urging court to reverse dismissal of Prevagen case.
The Latest
Prevagen Is Going to the Dogs
Second Circuit rules FTC/NY case against Prevagen can proceed.
2nd Circ. Saves FTC Oversight Of Red-Hot Memory Aid Sector
Jeff Overly, Law360
Don’t Fall for the ‘Memory’ Pills Targeting Baby Boomers
Emily Dreyfuss, WIRED
Clear-cut fraud? Quincy Bioscience faces a potentially ruinous lawsuit over memory claims
Marc Eisen, Isthmus
Marketers exploit the aged with unproven brain-health claims
Rick Schmitt, Newsweek
Memory supplement from jellyfish doesn’t work, FTC says
Herb Weisbaum, Komo News
Prevagen’s Fishy Memory Claims Under Fire by Federal Regulators
Five things you should know about the FTC, New York lawsuit against Prevagen.
Which of these Products are April Fools?
Take this quiz to test your buyer beware prowess.
Ad Watchdog Calls Out Broadcast Networks for Airing Deceptive Ads
TINA.org Urges Better Screening MADISON, CONN., January 19, 2016 – Consumer advocacy organization, truthinadvertising.org (TINA.org), has put major broadcast networks on notice regarding deceptive advertising. The ad watchdog alerted ABC,…
TINA.org Alerts Major TV Networks to Deceptive Prevagen Ads
TINA.org also calls on the BBB to re-evaluate company’s A+ rating.
Class-Action Tracker
Prevagen
False advertising class-action lawsuits filed against Quincy Bioscience regarding its marketing of Prevagen